Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany*

By Thelen Ulrich   Buchholz Patricia   Kimmich Friedemann  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1003-1009

Informa Healthcare

Access to resources Recommend Favorite

Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database

By Lazaridou Marie-Noëlle   Montgomery Donald M. I.   Ho Whye Onn   Jaberoo David  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2725-2728

Informa Healthcare

Access to resources Recommend Favorite

CYP1B1 mutations in glaucoma patients

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 1, 2015-01 ,pp. : 31-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

A vascular comparison between primary open‐angle glaucoma and normal‐tension glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension

By Orme M.   Collins S.   Dakin H.   Kelly S.   Loftus J.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 511-528

Informa Healthcare

Access to resources Recommend Favorite